Ronald Schwartz, MD

NPI 1073559118ActiveIndividual· Internal Medicine, Cardiovascular Disease· Rochester, NY

Internal Medicine, Cardiovascular Disease (MD) in Rochester, New York, trained at University of Rochester School of Medicine and Dentistry (class of 1978). Their prescriptions cost Medicare Part D more than their services did: $984,064 for 3,940 claims, against $30,453 paid for services in 2024. Astrazeneca Pharmaceuticals LP reported $40.93 in payments in 2025, mostly food and beverage.

Overview

NPI	1073559118
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	No
NPI issued	Jun 20, 2006
Last updated in NPPES	Jul 3, 2023

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Cardiovascular Disease Primary	207RC0000X	162812	NY

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Cardiovascular Disease (Cardiology) (NY)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	309
Services billed	711 across 25 procedure codes
Paid by Medicare	$30,453

Part D prescriptions in 2024

Prescriptions (claims)	3,940 · 10,120 30-day fills
Patients	453
Total drug cost	$984,064
Generic share	81% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Rochester School of Medicine and Dentistry
Graduation year	1978
Medicare specialty	Cardiovascular Disease (Cardiology)
Secondary specialties	Nuclear Medicine